KONOWIECKI JOSEPH S sold $202K of ALHC

KONOWIECKI JOSEPH S (EVP, Corporate Affairs) sold 23,511 shares of Alignment Healthcare, Inc. (ALHC) at $8.61 ($0.20M total) on 2026-09-17.

Original reporting
SEC EDGAR · KONOWIECKI JOSEPH S
Published Sep 18, 2026, 8:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 18, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALHC
Neutral
medium confidence
Mentioned
$ALHC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALHCNeutralLow
01

Why it matters

The disclosed sale provides fresh data on insider sentiment for Alignment Healthcare.

02

Market read

Routine insider sale with modest size; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 4/10Novelty 4/10Timing: post-market 2026-09-18

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$ALHCNeutralMedium confidence
Context

EVP Joseph Konowiecki sold 23,511 shares of Alignment Healthcare for $202,430 in a Form 4 filing.

Expected impact

Potential short-term dip of 1-2% as the market digests the sale.

Evidence & confidence

Sale size is small ($202k) and represents a minor reduction of a large position; unlikely to drive major price movement.

Market effects

Minimal impact on the broader biotech sector.

No significant regional effect.

Limited to investors tracking Alignment Healthcare.

Counterpoint

Insider may be diversifying; sale does not imply lack of confidence.

Key entities

  • Alignment Healthcare, Inc.

    Biotech firm focused on oncology therapeutics.

  • Joseph S. Konowiecki

    Executive Vice President, Corporate Affairs.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.